Non-valvular Atrial Fibrillation (NVAF) Clinical Trial
Official title:
Treatment Satisfaction Under Rivaroxaban (ACTS/TSQM)
The objective of this study is to understand if Rivaroxaban can improve treatment
satisfaction of Warfarin patients and assess the safety and effectiveness of Xarelto in real
clinical practice.
A total of 725 patients are to be enrolled and followed for a 6 months.period. QOL survey
will be conducted at month 0, 3, 6 using ACTS/TSQM.
This study is categorized as a regulatory post-marketing surveillance in Japan, and it is a
local prospective and observational study of patients who have received Xarelto for SPAF.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05022758 -
A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin
|
||
| Active, not recruiting |
NCT03887780 -
A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)
|
||
| Completed |
NCT02954237 -
AMPLATZER™ Cardiac Plug Observational Post-Approval Study
|
||
| Completed |
NCT04356989 -
Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function
|
||
| Recruiting |
NCT05232643 -
A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
|
||
| Recruiting |
NCT03234114 -
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
|
Phase 4 | |
| Completed |
NCT03746301 -
Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation
|
||
| Completed |
NCT02663076 -
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
|
||
| Withdrawn |
NCT02153424 -
Early Post-marketing Study of Eliquis (Apixaban)
|
N/A | |
| Completed |
NCT05027061 -
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
|